Cancer Genetics, Inc.
(NASDAQ : CGIX)

( )
CGIX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.07%339.181.0%$566.77m
BDXBecton, Dickinson & Co. 2.27%260.111.1%$535.48m
MDTMedtronic Plc 0.36%117.250.6%$516.42m
ISRGIntuitive Surgical, Inc. 0.50%603.362.4%$437.66m
ABTAbbott Laboratories 1.09%89.650.8%$429.80m
DHRDanaher Corp. 1.55%165.950.7%$370.61m
EWEdwards Lifesciences Corp. 1.77%230.541.2%$354.69m
BSXBoston Scientific Corp. 0.26%42.291.1%$346.61m
SYKStryker Corp. 1.92%221.591.3%$338.35m
ALGNAlign Technology, Inc. 0.73%274.956.4%$253.51m
DXCMDexCom, Inc. 12.57%283.918.3%$221.64m
BAXBaxter International, Inc. 0.61%93.131.8%$217.92m
ZBHZimmer Biomet Holdings, Inc. 1.05%160.391.7%$167.56m
TNDMTandem Diabetes Care, Inc. 3.63%86.033.9%$144.59m
ABMDABIOMED, Inc. 1.47%167.223.3%$144.47m

Company Profile

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus::NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.